Adapting Critical Time Intervention to Support Inpatient Medical Care Transition
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Bronx, New York, United States, 10467
- Montefiore Medical Center
-
Bronx, New York, United States, 10457
- Bronx Care Health System
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 21 to 64 years old
- Diagnosis of schizophrenia
- Admitted to medical unit at collaborating hospital
- Admission diagnosis of Ambulatory Care Sensitive Condition
Exclusion Criteria:
- Not enrolled in Healthfirst Medicaid Managed Care plan for 12 months prior to admission
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Critical time intervention
Individuals who receive intensive care management during and following discharge from the inpatient medical unit.
|
Care management offered by individual with experience working with individuals with serious mental illness.
The care managers engage individuals before they are discharged from the hospital and work with them in the community to support linkages with medical and behavioral health care providers.
Care managers provide problem-solving, advice, and support to maximize patients' engagement in care.
|
|
NO_INTERVENTION: Treatment as usual
Individuals who receive routine care management during and following discharge from the inpatient medical unit.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
7 Days Hospital Inpatient All-cause Readmission Rates
Time Frame: Within 7 days following discharge
|
Rates of hospital inpatient readmission within 7 days following discharge
|
Within 7 days following discharge
|
|
30 Days Hospital Inpatient All-cause Readmission Rates
Time Frame: Within 30 days following discharge
|
Rates of hospital inpatient readmission within 30 days following discharge
|
Within 30 days following discharge
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants Who Follow up With Outpatient Medical Within 7 Days of Hospital Discharge
Time Frame: Within 7 days after discharge
|
Number of Participants who follow-up with outpatient medical attendance within 7 days of hospital discharge at follow-up appointments
|
Within 7 days after discharge
|
|
Number of Participants Who Follow-up With Outpatient Medical Within 30 Days of Hospital Discharge
Time Frame: Within 30 days after discharge
|
Number of Participants who follow-up with outpatient medical attendance within 30 days of hospital discharge at follow-up appointments
|
Within 30 days after discharge
|
|
Number of Participants Who Follow-up With Outpatient Mental Health Services Within 7 Days of Hospital Discharge
Time Frame: Within 7 days after discharge
|
Number of Participants who follow-up with Outpatient Mental Health Services attendance within 7 days of hospital discharge at follow-up appointments
|
Within 7 days after discharge
|
|
Number of Participants Who Follow-up With Outpatient Mental Health Services Within 30 Days of Hospital Discharge
Time Frame: Within 30 days after discharge
|
Number of Participants who follow-up with Outpatient Mental Health Services attendance within 30 days of hospital discharge at follow-up appointments
|
Within 30 days after discharge
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Thomas Smith, MD, New York State Psychiatric Institute
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 7657
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.